Clinical trials
Not yet recruiting Carcinoma, Hepatocellular trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 4 |
| 2024 | 9 |
| 2025 | 17 |
| 2026 | 35 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tongji Hospital | 7 |
| Xuhua Duan | 3 |
| Zhujiang Hospital | 3 |
| Chinese PLA General Hospital | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
| Peking Union Medical College Hospital | 2 |
| Shanghai Zhongshan Hospital | 2 |
| West China Hospital | 2 |
| Zhongda Hospital | 2 |
| Acepodia Biotech, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 67 |
| Neoplasm Metastasis | 3 |
| Recurrence | 3 |
| Cachexia | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Cholangiocarcinoma | 2 |
| Colorectal Neoplasms | 2 |
| Hepatitis B, Chronic | 2 |
| Anorexia | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.